Pharmaceutical Excipients Market, currently estimated at USD 7.8–8.0 billion (2024), is poised for substantial expansion in the coming decade, driven by rising demand from biologics, generics, and formulation innovation. Key growth drivers include increased R&D investment in novel excipient technologies and the shift toward patient-friendly, high-performance drug...